Can Psychedelics Solve Depression? | Christian Angermayer

On this episode

About this episode

This week’s American Alchemist is Christian Angermayer: entrepreneur, investor, and head of Apeiron Investment Group, which manages 3.5 Billion Dollars. Born and bred in Germany, Christian is the first investor in Compass Pathways and founder of Atai Life Sciences, demarginalizing psychedelics and bringing them into the mainstream as FDA-approved treatments and therapies for ailments like depression, addiction, and PTSD. Perhaps more interesting than his business track record is his personality; he’s both laser-focused and great at actualizing his goals, visualizing them with a specific method every morning before achieving them. In this interview, we get into everything from his goal…